Production (Stage)
Bio-Path Holdings, Inc.
BPTH
$0.18
-$0.01-5.26%
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 56.44% | -38.65% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 23.47% | -0.34% | |||
| Operating Income | -23.47% | 0.34% | |||
| Income Before Tax | -3.60% | -30.17% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -3.60% | -30.17% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -3.60% | -30.17% | |||
| EBIT | -23.47% | 0.34% | |||
| EBITDA | -24.29% | 0.84% | |||
| EPS Basic | 36.69% | 8.99% | |||
| Normalized Basic EPS | 36.71% | 8.97% | |||
| EPS Diluted | 36.69% | 8.99% | |||
| Normalized Diluted EPS | 36.71% | 8.97% | |||
| Average Basic Shares Outstanding | 63.66% | 43.02% | |||
| Average Diluted Shares Outstanding | 63.66% | 43.02% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||